文献
J-GLOBAL ID:202102242038186220
整理番号:21A2508378
重症のCOVID-19患者におけるサイトソルブ療法の使用: 根拠と現在の臨床経験のレビュー【JST・京大機械翻訳】
The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences
著者 (7件):
Ruiz-Rodriguez Juan Carlos
(Department of Intensive Care, Hospital Universitari Vall d’Hebron, Shock Organ Dysfunction and Resuscitation Research Group, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain)
,
Molnar Zsolt
(CytoSorbents Europe GmbH, Berlin, Germany)
,
Molnar Zsolt
(Institute for Translational Medicine, School of Medicine, University of Pecs, Pecs, Hungary)
,
Molnar Zsolt
(Department of Anesthesiology and Intensive Therapy, Poznan University of Medical Sciences, Poznan, Poland)
,
Molnar Zsolt
(Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary)
,
Deliargyris Efthymios N.
(CytoSorbents Corporation, Monmouth Junction, NJ, USA)
,
Ferrer Ricard
(Department of Intensive Care, Hospital Universitari Vall d’Hebron, Shock Organ Dysfunction and Resuscitation Research Group, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain)
資料名:
Critical Care Research and Practice (Web)
(Critical Care Research and Practice (Web))
巻:
2021
ページ:
Null
発行年:
2021年
JST資料番号:
U7695A
ISSN:
2090-1305
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
イギリス (GBR)
言語:
英語 (EN)